MedPath

Nabiqasim Industries (Pvt) Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (100.0%)

Glycemic Control with Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Phase 4
Not yet recruiting
Conditions
Diabetes Mellitus
Type 2 DM
First Posted Date
2025-03-06
Last Posted Date
2025-03-06
Lead Sponsor
Nabiqasim Industries (Pvt) Ltd
Target Recruit Count
800
Registration Number
NCT06862739

Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy

Phase 4
Conditions
Irritable Bowel Syndrome
Interventions
First Posted Date
2015-03-12
Last Posted Date
2015-03-17
Lead Sponsor
Nabiqasim Industries (Pvt) Ltd
Target Recruit Count
40
Registration Number
NCT02386904
Locations
🇵🇰

National Institute of Liver and GI diseases, DUHS, Karachi, Sindh, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.